XENAZINE (tetrabenazine) is a medicine that is used to treat the involuntary movements (chorea) of Huntington’s disease. XENAZINE does not cure the cause of the involuntary movements, and it does not treat other symptoms of Huntington’s disease, such as problems with thinking or emotions.

It is not known whether XENAZINE is safe and effective in children.

Other Patient Support Programs Terms and Conditions

Informational support provided through the Lundbeck Xenazine Information Center (“Informational Support”) is available for eligible Xenazine patients only.  Informational Support should not replace conversations between patients and their health care providers or their office staff, is not insurance or a guarantee of coverage or assistance, and has no independent value. 

Patients are eligible for Informational Support if they have a valid prescription for Xenazine and a request is submitted to the Xenazine Information Center using a completed Xenazine Treatment Form.  Informational Support includes insurance coverage information related to Xenazine and, depending on patient eligibility, information regarding other Lundbeck patient support programs.  Separate applications may be required for Lundbeck programs to determine patient eligibility.

There may be other ways for patients to obtain assistance verifying insurance coverage for, and/or affording the cost of Xenazine.  Questions regarding other possible sources of patient support should be directed to the patient’s health care provider. 

There is no purchase requirement associated with Informational Support.  Informational Support is only provided in the USA where allowed by law. Informational Support is intended to comply with all applicable laws and regulations, including, without limitation, the federal Anti-Kickback Statute, its implementing regulations, and related guidance interpreting the federal Anti-Kickback Statute. Lundbeck reserves the right to rescind, revoke, or amend Informational Support without notice.  Questions regarding Informational Support that may be available to a patient and opt-out requests should be directed to the Xenazine Information Center: Monday-Friday, 8:00 a.m. to 6:00 p.m. ET. 1-888-882-6013.

Terms and Conditions for the Xenazine Copay Assistance Program

Terms and Conditions:  Only commercially insured patients age 17 and older whose insurance policy provides coverage for Xenazine® (tetrabenazine) and who are not reimbursed for the entire cost of the prescription are eligible for the copay assistance (the “Offer”).  Patients are not eligible for the Offer if they are self-pay or if the prescription is eligible to be reimbursed, in whole or in part, by any state or federal health care programs, including but not limited to Medicare or Medicaid, Medigap, VA, DOD, or TRICARE.  In addition, patients may not use the Offer if they are Medicare-eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees.  

The Offer is valid only for use with a valid prescription for Xenazine at the time the prescription is filled by the pharmacist and dispensed to the patient. The Offer applies only to prescriptions filled before the program expires or terminates. The copay prescriptions shall not be submitted for reimbursement to any public third-party payer, including Medicaid or Medicare, or any other similar federal or state healthcare program.  Patients are responsible for complying with any obligations or requirements imposed by their insurance plans.

The Offer is not transferable. The selling, purchasing, trading, or counterfeiting of the Offer is prohibited by law. The Offer has no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription.

Lundbeck reserves the right to rescind, revoke, terminate or amend the Offer without notice. The Offer is intended to comply with all applicable laws and regulations, including, without limitation, the federal Anti-Kickback Statute, its implementing regulations, and related guidance interpreting the federal Anti-Kickback Statute. The Offer is not health insurance. The Offer is valid only in the USA where allowed by law. There is no future purchase requirement associated with the Offer. Patient questions and requests to discontinue participation in the program can be directed to 1-888-882-6013 (8:00 am-6:00 pm ET, Monday through Friday).

Eligible commercially insured patients age 17 and older with a valid Xenazine prescription may participate in this program. Patients must pay at least $10 for each 30-day prescription. A maximum benefit limit may also apply. If the patient’s total out-of-pocket pharmacy bill exceeds the cap established by Lundbeck, the patient will be responsible for the additional balance. Patients should confirm their out-of-pocket cost with their pharmacy at the time the pharmacy calls to dispense the prescription. By participating in the Copay Assistance program, the patient acknowledges and agrees that he/she is eligible to participate and that he/she understands and agrees to comply with the General and Copay Assistance Terms and Conditions.

To the Pharmacist:

  • Submit transaction to McKesson Corporation using BIN #610524.
  • Input card information as secondary coverage and transmit using the COB segment of the NCPDP transaction. Applicable discounts will be displayed in the transaction response.
  • Acceptance of this card and your submission of claims are subject to the LoyaltyScript® program. Terms and Conditions posted at www.mckesson.com/mprstnc.
  • For questions regarding claim transmission call the LoyaltyScript® program at 1-800-657-7613 (8:00 am-8:00 pm ET, Monday through Friday).
  • For questions regarding patient eligibility or other issues, call the Xenazine Information Center at 1-888-882-6013 (8:00 am-6:00 pm ET, Monday through Friday).

 

IMPORTANT SAFETY INFORMATION

  • XENAZINE can cause serious side effects, including:
    • depression
    • suicidal thoughts
    • suicidal actions
  • You should not start taking XENAZINE if you are depressed (have untreated depression or depression that is not well controlled by medicine) or have suicidal thoughts.
  • Pay close attention to any changes, especially sudden changes, in mood, behaviors, thoughts or feelings, or worsening depression. This is especially important when XENAZINE is started and when the dose is changed.

IMPORTANT SAFETY INFORMATION

  • XENAZINE can cause serious side effects, including:
    • depression
    • suicidal thoughts
    • suicidal actions
  • You should not start taking XENAZINE if you are depressed (have untreated depression or depression that is not well controlled by medicine) or have suicidal thoughts.
  • Pay close attention to any changes, especially sudden changes, in mood, behaviors, thoughts or feelings, or worsening depression. This is especially important when XENAZINE is started and when the dose is changed.
  • Do not take XENAZINE if you have liver problems or are taking monoamine oxidase inhibitors (MAOIs), reserpine, deutetrabenazine or valbenazine. Ask your doctor or pharmacist if you are not sure. You must wait at least 20 days after stopping reserpine before starting XENAZINE.
  • Tell your doctor if you have breast cancer or a history of breast cancer, have heart disease or an irregular heartbeat, are pregnant or plan to become pregnant, or are breastfeeding.
  • Tell your doctor about all the medicines you take. Using XENAZINE with certain other medicines may cause serious side effects. Do not start any new medicines while taking XENAZINE without talking to your doctor first.
  • Take XENAZINE exactly as prescribed by your doctor. The dose of XENAZINE should be increased slowly over several weeks to find a dose that is best for you. Do not stop taking XENAZINE without talking to your doctor first. Tell your doctor if you stop taking XENAZINE for more than 5 days. Do not take another dose until you talk to your doctor. If your doctor thinks you need to take more than 50 mg of XENAZINE each day, you will need to have a blood test to see if a higher dose is safe for you. Your doctor should evaluate your need for XENAZINE on an ongoing basis.
  • Neuroleptic Malignant Syndrome (NMS) is a potentially fatal side effect reported with XENAZINE. Call your doctor right away and go to the nearest emergency room if you develop these signs and symptoms that do not have another obvious cause: high fever, stiff muscles, problems thinking, very fast or uneven heartbeat, or increased sweating. Your doctor should stop XENAZINE immediately if NMS is diagnosed.
  • XENAZINE can also cause other serious side effects, including: Parkinsonism (slight shaking, body stiffness, trouble moving, or keeping your balance), restlessness (feeling of a strong urge to move called akathisia), irregular heartbeat, and dizziness due to blood pressure changes when you change position (orthostatic hypotension). Change positions slowly from lying down to sitting up and from sitting up to standing when taking XENAZINE. Tell your doctor right away if you get dizzy or faint while taking XENAZINE.
  • The risk of side effects, such as, Parkinsonism, NMS, and restlessness (akathisia), may be increased when using XENAZINE with other drugs (e.g., dopamine antagonists or antipsychotics).
  • Sleepiness (sedation) is a common side effect of XENAZINE. Do not drive a car or operate dangerous machinery until you know how XENAZINE affects you. Drinking alcohol and taking other drugs may increase any sleepiness caused by XENAZINE.
  • The most commonly reported side effects in studies with XENAZINE were sleepiness (sedation), trouble sleeping, depression, tiredness (fatigue), anxiety, restlessness, agitation, and nausea.

For more information, please see the Medication Guide  and  full Prescribing Information, including Boxed Warning for depression and suicidality, or go to www.XenazineUSA.com.

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The product information provided in this site is intended only for residents of the U.S. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider.

 

Xenazine is a registered trademark of Bausch Health Companies Inc. or its affiliates.

©2024 Lundbeck, Deerfield, IL 60015. All rights reserved.

TBZ-B-100001v4